stoxline Quote Chart Rank Option Currency Glossary
  
MediWound Ltd. (MDWD)
20.46  0.41 (2.04%)    07-18 16:00
Open: 20.24
High: 21.03
Volume: 76,326
  
Pre. Close: 20.05
Low: 20.1
Market Cap: 221(M)
Technical analysis
2025-07-18 4:42:52 PM
Short term     
Mid term     
Targets 6-month :  24.82 1-year :  28.99
Resists First :  21.25 Second :  24.82
Pivot price 19.84
Supports First :  19.55 Second :  18.5
MAs MA(5) :  20.19 MA(20) :  19.71
MA(100) :  18.52 MA(250) :  18.09
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  54.1 D(3) :  52.3
RSI RSI(14): 55.5
52-week High :  22.5 Low :  14.14
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MDWD ] has closed below upper band by 24.7%. Bollinger Bands are 27.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 21.05 - 21.13 21.13 - 21.22
Low: 19.88 - 19.97 19.97 - 20.07
Close: 20.3 - 20.44 20.44 - 20.6
Company Description

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

Headline News

Mon, 30 Jun 2025
MediWound Ltd.(NasdaqGM: MDWD) added to Russell Small Cap Comp Value Index - MarketScreener

Wed, 21 May 2025
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Fri, 21 Mar 2025
MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Lo - GuruFocus

Thu, 20 Mar 2025
MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue G - GuruFocus

Wed, 19 Mar 2025
MediWound Reports 2024 Financials and Strategic Advances - TipRanks

Wed, 19 Mar 2025
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 11 (M)
Shares Float 8 (M)
Held by Insiders 17.9 (%)
Held by Institutions 43.5 (%)
Shares Short 917 (K)
Shares Short P.Month 962 (K)
Stock Financials
EPS -2.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.9
Profit Margin -110.5 %
Operating Margin -132.2 %
Return on Assets (ttm) -19.9 %
Return on Equity (ttm) -78 %
Qtrly Rev. Growth -20.3 %
Gross Profit (p.s.) 0.25
Sales Per Share 1.77
EBITDA (p.s.) -1.86
Qtrly Earnings Growth 0 %
Operating Cash Flow -13 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio -9.99
PEG Ratio 0
Price to Book value 7.05
Price to Sales 11.51
Price to Cash Flow -16.85
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android